Mediforum Ltd., Co.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease (NCT05811000) | Mediforum Ltd., Co. | 2020-11-27 |
Track Mediforum Ltd., Co. automatically
Every clearance here is in the API, with alerts when new ones post.